Clinical Trial Update: KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy [Phase 2]

View source ↗

Summary

An open-label Phase 2 pilot study evaluating Oxatomide in steroid-naive Duchenne muscular dystrophy. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Oxatomide (Oxatomide)

Snippet

Sponsor: Cooperative International Neuromuscular Research Group | Conditions: Muscular Dystrophy, Duchenne | Phase 2 | Status: COMPLETED